Legal & General Group PLC Repligen Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Legal & General Group PLC holds 87,602 shares of RGEN stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,602
Previous 87,602 -0.0%
Holding current value
$10.9 Million
Previous $13 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.79 - $167.35 $16.9 Million - $23.6 Million
-140,761 Reduced 61.64%
87,602 $13 Million
Q2 2024

Aug 14, 2024
SELL
$120.0 - $182.95 $853,080 - $1.3 Million
-7,109 Reduced 3.02%
228,363 $28.8 Million
Q1 2024

Jul 01, 2024
BUY
$170.78 - $208.42 $16,907 - $20,633
99 Added 0.04%
235,472 $43.3 Million
Q1 2024

May 14, 2024
SELL
$170.78 - $208.42 $532,150 - $649,436
-3,116 Reduced 1.31%
235,373 $43.3 Million
Q4 2023

Feb 15, 2024
BUY
$114.17 - $185.35 $4.85 Million - $7.88 Million
42,517 Added 21.7%
238,489 $42.9 Million
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $406,347 - $516,821
-2,928 Reduced 1.47%
195,972 $31.2 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $573,335 - $746,844
-4,142 Reduced 2.04%
198,900 $28.1 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $257,614 - $330,827
1,670 Added 0.83%
203,042 $34.2 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $17.3 Million - $23.5 Million
106,374 Added 111.97%
201,372 $34.1 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $2.26 Million - $3.62 Million
14,110 Added 17.44%
94,998 $17.8 Million
Q2 2022

Aug 22, 2022
SELL
$140.68 - $188.02 $140,961 - $188,396
-1,002 Reduced 1.22%
80,888 $13.1 Million
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $92,200 - $147,553
-572 Reduced 0.69%
81,890 $15.4 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $6.51 Million - $8.01 Million
-26,311 Reduced 24.19%
82,462 $21.8 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $7.6 Million - $12.6 Million
39,015 Added 55.93%
108,773 $31.4 Million
Q2 2021

Aug 12, 2021
SELL
$165.87 - $220.95 $2.26 Million - $3.01 Million
-13,630 Reduced 16.35%
69,758 $13.9 Million
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $619,390 - $776,976
3,434 Added 4.29%
83,388 $16.2 Million
Q4 2020

Feb 12, 2021
SELL
$148.08 - $206.57 $734,476 - $1.02 Million
-4,960 Reduced 5.84%
79,954 $15.3 Million
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $557,543 - $720,286
4,551 Added 5.66%
84,914 $12.5 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $1.57 Million - $2.34 Million
16,656 Added 26.14%
80,363 $9.93 Million
Q1 2020

May 14, 2020
BUY
$84.96 - $109.14 $42,819 - $55,006
504 Added 0.8%
63,707 $6.15 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $247,585 - $312,097
3,353 Added 5.6%
63,203 $5.85 Million
Q3 2019

Nov 13, 2019
SELL
$76.65 - $95.51 $4.03 Million - $5.02 Million
-52,611 Reduced 46.78%
59,850 $4.59 Million
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $625,739 - $992,292
11,545 Added 11.44%
112,461 $9.67 Million
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $428,335 - $543,973
8,662 Added 9.39%
100,916 $5.96 Million
Q4 2018

Feb 15, 2019
BUY
$48.26 - $68.88 $90,197 - $128,736
1,869 Added 2.07%
92,254 $4.83 Million
Q3 2018

Nov 20, 2018
BUY
$46.8 - $58.97 $410,108 - $516,754
8,763 Added 10.74%
90,385 $4.98 Million
Q2 2018

Aug 10, 2018
BUY
$35.26 - $47.04 $159,657 - $212,997
4,528 Added 5.87%
81,622 $3.83 Million
Q1 2018

May 17, 2018
BUY
$30.92 - $37.27 $47,214 - $56,911
1,527 Added 2.02%
77,094 $2.77 Million
Q4 2017

Feb 13, 2018
BUY
$32.53 - $38.92 $2.46 Million - $2.94 Million
75,567
75,567 $2.74 Million

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email